Increased frequency of CD4 +CD25 highFoxP3 + regulatory T cells in patients with hepatocellular carcinoma

Archivum Immunologiae et Therapiae Experimentalis

Volumn 59, Issue 4, 2011, Pages 309-314

  Feng, Xi ^a   Li, Bo ^a   Ye, Hui ^a   Long, Dan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

CD4 +CD25 highFoxP3 +; Hepatocellular carcinoma; IL 10; TGF 1; Treg

Indexed keywords

CD4 ANTIGEN; DNA; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER RESECTION; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY;

ANTIGENS, CD4; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIVER NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTES, TUMOR-INFILTRATING; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79959605064     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-011-0127-0     Document Type: Article

References (37)

1. Baecher-Allan C, Brown JA, Freeman GJ et al (2001) CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167:1245-1253 (Pubitemid 32703119)
2. Banham AH, Powrie FM, Suri-Payer E (2006) FOXP3+regulatory T cells: current controversies and future perspectives. Eur J Immunol 36:2832-2836 (Pubitemid 44782555)
3. Barrat FJ, Cua DJ, Boonstra A et al (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195:603-616
4. Cesana GC, DeRaffele G, Cohen S et al (2006) Characterization of CD4+ CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. J Clin Oncol 24:1169-1177 (Pubitemid 46638815)
5. + T cells with regulatory properties from human blood. J Exp Med 193:1303-1310
6. + regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med 196:247-253
7. + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 202:1075-1085
8. Grossman W, Verbsky J, Berchet W et al (2004) Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21:589-601 (Pubitemid 39370513)
9. Harada N, Shimada M, Okano S et al (2004) IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice. J Immunol 173:6635-6644 (Pubitemid 39541047)
10. +CD25 high regulatory T cells. Blood 104:895-903
11. + T cells. Adv Immunol 81:331-371
12. +CD25 high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J Immunol 176:5293-5298
13. Ichihara F, Kono K, Takahashi A et al (2003) Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 9:4404-4408 (Pubitemid 37248397)
14. + suppressor lymphocytes in the circulation of patients immunized against melanoma antigens. J Immunother 26:85-93
15. + T helper cells. J Exp Med 196:255-260
16. Knutson KL, Disis ML, Salazar LG (2007) CD4 regulatory T cells in human cancer pathogenesis. Cancer Immunol Immunother 56:271-285 (Pubitemid 46035899)
17. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193:1295-1302
18. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907-1917 (Pubitemid 37518510)
19. McHugh RS, Shevach EM (2002) The role of suppressor T cells in regulation of immune responses. J Allergy Clin Immunol 110:693-702 (Pubitemid 35423170)
20. + regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194:629-644
21. Ormandy LA, Hillemann T, Wedemeyer H et al (2005) Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 65:2457-2464 (Pubitemid 40490158)
22. + regulatory T cells. Trends Immunol 25:374-380
23. Powrie F, Read S, Mottet C et al (2003) Control of immune pathology by regulatory T cells. Novartis Found Symp 252:92-98 [discussion 98-105, 106-114]
24. Sakaguchi S, Sakaguchi N, Asano M et al (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-1164
25. Sasada T, Kimura M, Yoshida Y et al (2003) CD4 + CD25 + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98:1089-1099 (Pubitemid 37022112)
26. + regulatory T cells in the peripheral circulation of patients with head and neck cancer. Br J Cancer 92:913-920
27. Shabtai M, Ye H, Kono K et al (2003) Immune inhibitory effects of renal cell carcinoma extract on lectin and alloantigen-induced peripheral blood and tumor infiltrating lymphocyte blastogenesis. Urol Oncol 21:27-32 (Pubitemid 41115112)
28. + suppressor T cells: more questions than answers. Nat Rev Immunol 2:389-400
29. Strauss L, Bergmann C, Szczepanski M et al (2007) A unique subset of CD4 + CD25highFoxp3 + T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin Cancer Res 13(15 Pt 1): 4345-4354 (Pubitemid 47219698)
30. Sundstedt A, O'Neill EJ, Nicolson KS et al (2003) Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J Immunol 170:1240-1248 (Pubitemid 36139489)
31. Takagi S, Chen K, Schwarz R et al (1989) Functional and phenotypic analysis of tumor-infiltrating. Lymphocytes isolated from human primary and metastatic: liver tumors and cultured in recombinant interleukin-2. Cancer 63:102-111
32. + regulatory T cells. J Leukoc Biol 80: 458-470
33. Woo EY, Chu CS, Goletz TJ et al (2001) Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 61:4766-4772 (Pubitemid 32691889)
34. + regulatory T-cells in the liver of patients with hepatocellular carcinoma. J Hepatol 45:254-262
35. + regulatory T cells in the peripheral blood of patients with prostate cancer. Clin Cancer Res 14:1032-1040
36. + regulatory T cells by oral antigen administration. J Immunol 167:4245-4253
37. Zhang J, Dong Z, Zhou R et al (2005) Isolation of lymphocytes and their innate immune characterizations from liver, intestine, lung and uterus. Cell Mol Immunol 2:271-280